Resources
Public references that inform our safety-first approach, scope boundaries, and patient empowerment posture.
Policy & Safety references
FDA — Clinical Decision Support (CDS)
We design as assistive software with clinician control and clear labeling, aligned to CDS principles.
Reference: FDA Clinical Decision Support Software Guidance (example citation).
HHS — No “HIPAA certification”
We avoid misleading badges and focus on practical safeguards and BAAs where applicable.
Reference: HHS HIPAA FAQs on “certifying” compliance.
CMS — Patient access & interoperability
CMS initiatives emphasize patient access and reducing repeated manual history collection.
Reference: CMS Health Tech Ecosystem (example citation).
Market context
Chronic disease cost burden
Chronic and mental health conditions drive a large share of U.S. health spending, reinforcing the need for continuous, practical support between visits.
Reference: CDC chronic disease statistics (example citation).
Notes on terminology
- • We avoid “diagnose” / “treat” language in marketing copy.
- • We use “assist,” “draft,” “summarize,” “organize,” and “guide to care when needed.”
- • We label educational information separately from clinician-directed outputs.
Medical disclaimer
Content is for informational purposes only and is not medical advice. For emergencies, call 911 or your local emergency number.
P.Ai Global Health Overview Deck
This presentation summarizes the platform vision, product workflow, architecture, and global impact of P.Ai Global Health.
Download Investor Deck (PDF)